Results 1 to 7 of 7
Hybrid View
-
06-21-2006, 10:55 AM #1OPSenior Member
AMA: Helping Doctors Help Patients
RECOMMENDATION 1: Research should continue into the physiological effects of synthetic and plant-derived cannabinoids and the natural function of cannabinoids found in the body. Because different cannabinoids appear to have different effects, cannabinoids research should include, but not be restricted to, effects attributable to THC alone.
Scientific data indicate the potential therapeutic value of cannabinoid drugs for pain relief, control of nausea and vomiting, and appetite stimulation. This value would be enhanced by a rapid onset of drug effect.
RECOMMENDATION 2: Clinical trials of cannabinoid drugs for symptom management should be conducted with the goal of developing rapid-onset, reliable, and safe delivery systems.
The psychological effects of cannabinoids are probably important determinants of their potential therapeutic value. They can influence symptoms indirectly which could create false impressions of the drug effect or be beneficial as a form of adjunctive therapy.
RECOMMENDATION 3: Psychological effects of cannabinoids such as anxiety reduction and sedation, which can influence medical benefits, should be evaluated in clinical trials.
Numerous studies suggest that marijuana smoke is an important risk factor in the development of respiratory diseases, but the data that could conclusively establish or refute this suspected link have not been collected.
RECOMMENDATION 4: Studies to define the individual health risks of smoking marijuana should be conducted, particularly among populations in which marijuana use is prevalent.
Because marijuana is a crude THC delivery system that also delivers harmful substances, smoked marijuana should generally not be recommended for medical use. Nonetheless, marijuana is widely used by certain patient groups, which raises both safety and efficacy issues.
RECOMMENDATION 5: Clinical trials of marijuana use for medical purposes should be conducted under the following limited circumstances: trials should involve only short-term marijuana use (less than six months), should be conducted in patients with conditions for which there is reasonable expectation of efficacy, should be approved by institutional review boards, and should collect data about efficacy.
If there is any future for marijuana as a medicine, it lies in its isolated components, the cannabinoids and their synthetic derivatives. Isolated cannabinoids will provide more reliable effects than crude plant mixtures. Therefore, the purpose of clinical trials of smoked marijuana would not be to develop marijuana as a licensed drug but rather to serve as a first step toward the development of nonsmoked rapid-onset cannabinoid delivery systems.
RECOMMENDATION 6: Short-term use of smoked marijuana (less than six months) for patients with debilitating symptoms (such as intractable pain or vomiting) must meet the following conditions:
* failure of all approved medications to provide relief has been documented,
* the symptoms can reasonably be expected to be relieved by rapid-onset cannabinoid drugs,
* such treatment is administered under medical supervision in a manner that allows for assessment of treatment effectiveness, and
* involves an oversight strategy comparable to an institutional review board process that could provide guidance within 24 house of a submission by a physician to provide marijuana to a patient for a specified use.
Featured Report:
Medical Marijuana (A-01) Full Text
Originally Posted by http://www.ama-assn.org/ama/pub/category/13625.html
beachguy in thongs Reviewed by beachguy in thongs on . AMA: Helping Doctors Help Patients RECOMMENDATION 1: Research should continue into the physiological effects of synthetic and plant-derived cannabinoids and the natural function of cannabinoids found in the body. Because different cannabinoids appear to have different effects, cannabinoids research should include, but not be restricted to, effects attributable to THC alone. Scientific data indicate the potential therapeutic value of cannabinoid drugs for pain relief, control of nausea and vomiting, and appetite stimulation. Rating: 5
-
06-21-2006, 10:56 AM #2Senior Member
AMA: Helping Doctors Help Patients
oh man.. im too tired to even read this
-
06-21-2006, 11:09 AM #3OPSenior Member
AMA: Helping Doctors Help Patients
Go to bed, Genie!
-
06-21-2006, 11:12 AM #4Senior Member
AMA: Helping Doctors Help Patients
i really dont feel like it
genie?
-
06-21-2006, 11:30 AM #5OPSenior Member
AMA: Helping Doctors Help Patients
Jeanie? I don't know. Le monde on le monde.
-
06-22-2006, 01:05 PM #6Senior Member
AMA: Helping Doctors Help Patients
You got some good points their beach guy
-
06-22-2006, 08:11 PM #7OPSenior Member
AMA: Helping Doctors Help Patients
Originally Posted by GratefulDead4ever
Advertisements
Similar Threads
-
patients selling extra meds to patients
By valstar in forum Colorado (CO)Replies: 19Last Post: 08-07-2010, 02:45 PM -
Aurora continues battle against patients... and doctors
By copobo in forum Colorado (CO)Replies: 10Last Post: 07-11-2010, 07:15 PM -
Patients Helping Patients
By Dorje113 in forum Colorado (CO)Replies: 19Last Post: 05-29-2010, 04:31 AM -
No# Patients to Doctors
By personified in forum New Mexico (NM)Replies: 8Last Post: 02-19-2010, 04:54 AM -
AMA: Helping Doctors Help Patients
By in forum GreenGrassForums LoungeReplies: 0Last Post: 01-01-1970, 12:00 AM